SI21301A - Farmacevtska oblika z nadzorovanim sproščanjem - Google Patents

Farmacevtska oblika z nadzorovanim sproščanjem Download PDF

Info

Publication number
SI21301A
SI21301A SI200200220A SI200200220A SI21301A SI 21301 A SI21301 A SI 21301A SI 200200220 A SI200200220 A SI 200200220A SI 200200220 A SI200200220 A SI 200200220A SI 21301 A SI21301 A SI 21301A
Authority
SI
Slovenia
Prior art keywords
ketoprofen
pellet cores
pharmaceutical formulation
hours
pharmaceutical
Prior art date
Application number
SI200200220A
Other languages
English (en)
Slovenian (sl)
Inventor
Judita Širca
Milojka Mohar
Original Assignee
LEK farmacevtska družba d.d.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LEK farmacevtska družba d.d. filed Critical LEK farmacevtska družba d.d.
Priority to SI200200220A priority Critical patent/SI21301A/sl
Priority to EP03795550A priority patent/EP1539113A2/fr
Priority to AU2003261067A priority patent/AU2003261067A1/en
Priority to PCT/SI2003/000033 priority patent/WO2004024128A2/fr
Publication of SI21301A publication Critical patent/SI21301A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SI200200220A 2002-09-11 2002-09-11 Farmacevtska oblika z nadzorovanim sproščanjem SI21301A (sl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SI200200220A SI21301A (sl) 2002-09-11 2002-09-11 Farmacevtska oblika z nadzorovanim sproščanjem
EP03795550A EP1539113A2 (fr) 2002-09-11 2003-09-10 Composition pharmaceutique a liberation modifiee
AU2003261067A AU2003261067A1 (en) 2002-09-11 2003-09-10 Modified release ketoprofen dosage form
PCT/SI2003/000033 WO2004024128A2 (fr) 2002-09-11 2003-09-10 Composition pharmaceutique a liberation modifiee

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200200220A SI21301A (sl) 2002-09-11 2002-09-11 Farmacevtska oblika z nadzorovanim sproščanjem

Publications (1)

Publication Number Publication Date
SI21301A true SI21301A (sl) 2004-04-30

Family

ID=31989658

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200200220A SI21301A (sl) 2002-09-11 2002-09-11 Farmacevtska oblika z nadzorovanim sproščanjem

Country Status (4)

Country Link
EP (1) EP1539113A2 (fr)
AU (1) AU2003261067A1 (fr)
SI (1) SI21301A (fr)
WO (1) WO2004024128A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
PT1897558E (pt) * 2005-06-09 2013-11-06 Norgine Bv Preparação sólida de 2-hexadeciloxi-6-metil-4h-3,1- benzoxazin-4-ona
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
KR100762847B1 (ko) * 2006-01-27 2007-10-04 씨제이 주식회사 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법
CA2648278C (fr) * 2006-04-03 2019-05-28 Isa Odidi Composition d'administration de medicament
CN101453993A (zh) 2006-04-03 2009-06-10 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
RU2602188C2 (ru) * 2010-06-16 2016-11-10 Такеда Фармасьютикалз Ю.Эс.Эй.,Инк. Фармацевтическая композиция с модифицированным высвобождением, включающая фебуксостат
ES2394888B1 (es) * 2011-06-15 2013-09-23 Farmalider, S.A. Forma farmacéutica de liberación modificada de dexketoprofeno e inhibidor de la bomba de protones y uso de la misma.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
CN1277550A (zh) * 1997-09-11 2000-12-20 尼科梅德丹麦有限公司 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物
FR2792527B1 (fr) * 1999-04-22 2004-08-13 Ethypharm Lab Prod Ethiques Microgranules de ketoprofene, procede de preparation et compositions pharmaceutiques

Also Published As

Publication number Publication date
WO2004024128A2 (fr) 2004-03-25
EP1539113A2 (fr) 2005-06-15
WO2004024128A3 (fr) 2004-07-08
AU2003261067A8 (en) 2004-04-30
AU2003261067A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
US5496561A (en) Controlled release-initiation and controlled release-rate pharmaceutical composition
EP3154523B1 (fr) Formulation pour administration par voie orale contenant de la mésalazine
AU639519B2 (en) Controlled absorption naproxen formulation for once-daily administration
CA2068402C (fr) Enrobage pour masquer le gout pouvant etre utilise dans des comprimes pharmaceutiques croquables
JP4999037B2 (ja) 複数のコーティングを有する医薬剤形
US9446002B2 (en) Spheroids and multiparticulate tablets comprising them
US5277916A (en) Tetracycline dosage form
CA2563689A1 (fr) Forme galenique orale microparticulaire pour la liberation prolongee et controlee de principes actifs pharmaceutiques
JP2001526213A (ja) 経口医薬パルス放出剤形
US20210220281A1 (en) Oral pharmaceutical compositions of mesalazine
US20100183714A1 (en) Gastroresistant pharmaceutical dosage form comprising n-(2-(2- phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)
CA2967647A1 (fr) Formulation de bille pharmaceutique comprenant du fumarate de dimethyle
US20100305163A1 (en) Pharmaceutical formulations comprising nsaid and proton pump inhibitor drugs
US6197347B1 (en) Oral dosage for the controlled release of analgesic
US11622938B2 (en) Oral pharmaceutical compositions of nicotinamide
SI21301A (sl) Farmacevtska oblika z nadzorovanim sproščanjem
AU2008365126A1 (en) Tamsulosin pellets for fixed dose combination
EP2533766A2 (fr) Mini-pastilles pharmaceutiques destinées à la libération prolongée d'acétate de flécaïnide
US20150366850A1 (en) Modified release pharmaceutical compositions of dexmethylphenidate or salts thereof
US20090136550A1 (en) Modified release formulations of diltiazem
CA2547586C (fr) Formulation pharmaceutique a liberation controlee
RU2292877C2 (ru) Лекарственная ретард-форма, содержащая сахаринат трамадола
US20100105738A1 (en) Extended release formulations of a proton pump inhibitor
EA043403B1 (ru) Пеллета с многослойной структурой для замедленного высвобождения действующего вещества в дистальный отдел толстой кишки
MXPA06007316A (en) Controlled-release pharmaceutical formulation

Legal Events

Date Code Title Description
IF Valid on the prs date
KO00 Lapse of patent

Effective date: 20100630